Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Clinical trial NCT01814813 · TERMINATED
Trial details
- NCT number
- NCT01814813
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-19
- Primary completion
- 2017-04-03
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.